Data supports Sight Sciences' Omni surgical system for glaucoma
Sight Sciences announced today that 36-month data supports the use of its Omni surgical system.
Source: massdevice.com
📰 Karsten Klabe News
Karsten Klabe News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Karsten Klabe. Real-time updates on events, politics, business and more.
Glaukos Corporation: Glaukos Technologies Featured in Numerous Scientific Abstracts at the 2021 European Society of Cataract and Refractive Surgeons Annual Meeting
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced
Source: finanznachrichten.de